Medication Assisted Treatment (MAT)

The 2022 AMA-Manatt Toolkit builds on a previously published roadmap by providing actionable resources that states can use to take specific actions in six policy areas: (1) Increase access to evidence-based treatments to help patients with a substance use disorder (SUD); (2) Ensure access to addiction medicine, psychiatry, and other trained physicians; (3) Enforce mental health and substance use disorder (SUD) parity laws; (4) Improve access to multidisciplinary, multimodal care for patients with pain; (5) Expand harm reduction efforts to reduce death and disease; and (6) Improve monitoring and evaluation....

LAPPA’s Model Access to Medication for Addiction Treatment in Correctional Settings Act, written in collaboration with the O’Neill Institute for National and Global Health Law at the Georgetown University Law Center and a cadre of subject matter experts, sets forth a comprehensive, evidence-based framework for ensuring that all incarcerated individuals with a substance use disorder be provided access to FDA-approved medication for addiction treatment in state and local correctional settings....

Inmates have recently begun fighting back against state prison policies that ban MAT medications in correctional facilities by arguing in court cases that these policies violate the Americans with Disabilities Act and the Eighth Amendment of the United States Constitution. As courts begin to rule in favor of the inmates, states will need to reconsider their policies on MAT in correctional settings to avoid future lawsuits. ...